Management of psoriasis begins with identification of the extent of cutaneous disease.
However, a holistic, contractual approach to treatment is encouraged, with particular …

Background Chronic plaque psoriasis is the most common type of psoriasis, and it is
characterised by redness, thickness, and scaling. First‐line management of chronic plaque …

Psoriasis vulgaris is a common and often chronic inflammatory skin disease. The incidence
of psoriasis in Western industrialized countries ranges from 1.5% to 2%. Patients afflicted …

Background Topical psoriasis treatment relies on a reactive rather than a long-term
proactive approach to disease relapse. Objective Assess long-term efficacy and safety of …

Background: An aerosol foam formulation of fixed combination calcipotriene 0.005%(as
hydrate; Cal) plus betamethasone dipropionate 0.064%(BD) was developed to improve …

Background Fixed combination calcipotriol 50 μg/g (Cal) plus betamethasone 0.5 mg/g (BD)
foam has been developed as a new treatment option for patients with psoriasis. Methods …

Background Treatment adherence has been recognized as an important issue in the
management of chronic diseases such as psoriasis. Objective The aim of this work was to …

The majority of people with psoriasis have localized disease, where topical therapy forms
the cornerstone of treatment. We set out to summarize evidence on the relative efficacy …

Psoriasis encompasses a group of related immune‐mediated inflammatory skin diseases
that affect up to 3% of the population. These diseases are heritable and over 40 genetic …

Background: Topical corticosteroids and calcipotriol have been used separately for many
years to treat psoriasis. A new combination ointment has been formulated, which contains …